Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fruquintinib plus HAI-FOLFOX in refractory colorectal cancer
NCT06441565Phase 3Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Started May 2024; status: recruiting.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06441565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06441565.